Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans ...

Learn the hidden signs of sleep apnea, its impact on health, and how effective treatment can restore your energy and improve ...

Early management of obstructive sleep apnea in patients with IPF could slow disease progression and improve outcomes.

KBIA’s Rebecca Smith recently sat down with Dr. Mohammad Badran at the University of Missouri who studies sleep apnea to ...

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

Biotech firm Apnimed plans to seek FDA approval for its sleep apnea drug, with market availability expected by 2027 ...

LIVERPOOL, N.Y. (WSYR-TV) — Sleep apnea isn’t just something that affects older adults anymore. Experts say they’re seeing ...

DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As sleep disorders such as obstructive sleep apnea ...

Please provide your email address to receive an email when new articles are posted on . Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD.

Medical News Today looks at three key studies and their key findings that highlight and further confirm the connection between how poor sleep increases dementia risk.

Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...